MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

CUSIP: 62855J104

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
93,057,750
Total 13F shares
74,996,999
Share change
+1,534,551
Total reported value
$1,483,013,849
Put/Call ratio
83%
Price per share
$19.78
Number of holders
176
Value change
+$38,048,718
Number of buys
69
Number of sells
90

Quarterly Holders Quick Answers

What is CUSIP 62855J104?
CUSIP 62855J104 identifies MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2020

As of 31 Dec 2020, MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by 176 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,996,999 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, EARNEST PARTNERS LLC, Camber Capital Management LP, STATE STREET CORP, GLENVIEW CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., DIMENSIONAL FUND ADVISORS LP, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY. This page lists 176 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.